News and events
- All
- Events
- Press releases
- Publications
- All
- Events
- Press releases
- Publications
ExeVir Bio Appoints a Chief Scientific Officer
Ghent, Belgium, 1 September 2023: ExeVir Bio, a biotech company ...
Read More
ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research
Dengue is a mosquito borne viral infection listed by WHO as top 10 threat for global health The government grant is awarded by Flanders Innovation ...
Read More
Bio International Convention – June 5-8, 2023 – Boston, USA
Our CEO and COO are attending this partnering event in person to explore opportunities to collaborate in delivering new medicines to prevent and treat infectious ...
Read More
Antibody Engineering & Therapeutics Europe 2023 – June 6-8, 2023 – Amsterdam, The Netherlands
Our Head of Preclinical Development is attending this event in person to meet the antibody community.
Read More
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
Currently circulating SARS-CoV-2 variants have gained complete or significant resistance to all SARSCoV-2-neutralizing antibodies that have been used in the clinic. Such antibodies can prevent ...
Read More